FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

12661211000001107: Celsentri 300mg tablets (Pfizer Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
44895001000001116 Celsentri 300mg tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58054701000001116 Celsentri 300mg tablets (ViiV Healthcare UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Celsentri 300mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Is a Maraviroc 300mg tablets false Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Has active ingredient Maraviroc false Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Is a Celsentri true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Is a Product containing precisely maraviroc 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Has specific active ingredient Maraviroc true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Celsentri 300mg tablets (Pfizer Ltd) 60 tablet 6 x 10 tablets Is pack of False Celsentri 300mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Celsentri 300mg tablets (Pfizer Ltd) 60 tablet 6 x 10 tablets Has AMP True Celsentri 300mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start